Yamo Pharma doses first subject in Phase II autism spectrum disorder trial | #autism Clinical Trials Market
お気に入り
コメント
シェア
Yamo Pharma doses first subject in Phase II autism spectrum disorder trial | #autism Clinical Trials Market